{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:50:14Z","timestamp":1789480214114,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302799"],"award-info":[{"award-number":["81302799"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2013M531838"],"award-info":[{"award-number":["2013M531838"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"crossref","award":["KAB111133K08"],"award-info":[{"award-number":["KAB111133K08"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.canlet.2014.08.024","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T18:21:04Z","timestamp":1409077264000},"page":"28-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["The cyclooxygenase-2\/thromboxane A2 pathway: a bridge from rheumatoid arthritis to lung cancer?"],"prefix":"10.1016","volume":"354","author":[{"given":"Qing-Chun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3223-7657","authenticated-orcid":false,"given":"Run-Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.canlet.2014.08.024_bib0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.rmed.2007.10.022","article-title":"Clinical features of lung cancer in patients with connective tissue diseases: a 10-year hospital based study","volume":"102","author":"Adzic","year":"2008","journal-title":"Respir. Med"},{"issue":"5","key":"10.1016\/j.canlet.2014.08.024_bib0015","first-page":"958","article-title":"National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study","volume":"30","author":"Thomas","year":"2003","journal-title":"J. Rheumatol"},{"issue":"10","key":"10.1016\/j.canlet.2014.08.024_bib0020","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk","volume":"32A","author":"Mellemkjaer","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.canlet.2014.08.024_bib0025","first-page":"1484","article-title":"Excess risk of lung cancer in patients with rheumatoid arthritis","volume":"23","author":"Kauppi","year":"1996","journal-title":"J. Rheumatol"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0030","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthritis Res. Ther"},{"issue":"1","key":"10.1016\/j.canlet.2014.08.024_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/rheumatology\/kes350","article-title":"Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population","volume":"52","author":"Mercer","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.canlet.2014.08.024_bib0040","first-page":"1704","article-title":"Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans","volume":"35","author":"Khurana","year":"2008","journal-title":"J. Rheumatol"},{"issue":"11","key":"10.1016\/j.canlet.2014.08.024_bib0045","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00296-010-1524-0","article-title":"Incidence of malignancy in Japanese patients with rheumatoid arthritis","volume":"31","author":"Yamada","year":"2011","journal-title":"Rheumatol. Int"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0050","first-page":"158","article-title":"Cigarette smoking, cyclooxygenase-2 pathway and cancer","volume":"1815","author":"Huang","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.canlet.2014.08.024_bib0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/onc.2010.390","article-title":"4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor","volume":"30","author":"Huang","year":"2011","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.canlet.2014.08.024_bib0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00432-013-1573-3","article-title":"Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells","volume":"140","author":"Huang","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol"},{"issue":"5","key":"10.1016\/j.canlet.2014.08.024_bib0065","doi-asserted-by":"crossref","first-page":"L981","DOI":"10.1152\/ajplung.00239.2003","article-title":"Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer","volume":"287","author":"Martey","year":"2004","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol"},{"issue":"3","key":"10.1016\/j.canlet.2014.08.024_bib0070","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1734-1140(12)70857-5","article-title":"Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis","volume":"64","author":"Setia","year":"2012","journal-title":"Pharmacol. Rep"},{"issue":"6","key":"10.1016\/j.canlet.2014.08.024_bib0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002512-200724060-00001","article-title":"New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors","volume":"24","author":"Bansal","year":"2007","journal-title":"Drugs Aging"},{"issue":"26","key":"10.1016\/j.canlet.2014.08.024_bib0080","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.2174\/138161212802083707","article-title":"Molecular link mechanisms between inflammation and cancer","volume":"18","author":"Vendramini-Costa","year":"2012","journal-title":"Curr. Pharm. Des"},{"issue":"4","key":"10.1016\/j.canlet.2014.08.024_bib0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/ar2751","article-title":"Rheumatoid arthritis and smoking: putting the pieces together","volume":"11","author":"Baka","year":"2009","journal-title":"Arthritis Res. Ther"},{"issue":"92","key":"10.1016\/j.canlet.2014.08.024_bib0090","first-page":"75","article-title":"Novel insight into the role of alpha-actinin-1 in rheumatoid arthritis","volume":"17","author":"Huang","year":"2014","journal-title":"Discov. Med"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0095","first-page":"153","article-title":"The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer","volume":"1805","author":"Cathcart","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.canlet.2014.08.024_bib0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","article-title":"Thromboxane A2: physiology\/pathophysiology, cellular signal transduction and pharmacology","volume":"118","author":"Nakahata","year":"2008","journal-title":"Pharmacol. Ther"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.canlet.2010.09.012","article-title":"Targeting apoptosis pathways in lung cancer","volume":"332","author":"Pore","year":"2013","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.canlet.2014.08.024_bib0110","first-page":"1604","article-title":"Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors","volume":"9","author":"Ermert","year":"2003","journal-title":"Clin. Cancer Res"},{"issue":"8","key":"10.1016\/j.canlet.2014.08.024_bib0115","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/JTO.0b013e3181e2f4f5","article-title":"Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancer","volume":"5","author":"Wu","year":"2010","journal-title":"J. Thorac. Oncol"},{"issue":"10","key":"10.1016\/j.canlet.2014.08.024_bib0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molmed.2008.08.005","article-title":"Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology","volume":"14","author":"Harizi","year":"2008","journal-title":"Trends Mol. Med"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0125","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9440(10)63133-1","article-title":"Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility","volume":"164","author":"Nie","year":"2004","journal-title":"Am. J. Pathol"},{"issue":"5","key":"10.1016\/j.canlet.2014.08.024_bib0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbadis.2014.01.011","article-title":"Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer","volume":"1842","author":"Cathcart","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"3\u20134","key":"10.1016\/j.canlet.2014.08.024_bib0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10555-011-9297-9","article-title":"The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis","volume":"30","author":"Ekambaram","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.canlet.2014.08.024_bib0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-4598-10-25","article-title":"Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer","volume":"10","author":"Cathcart","year":"2011","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2014.08.024_bib0145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2174\/156800912801784884","article-title":"Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells","volume":"12","author":"Li","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"issue":"17","key":"10.1016\/j.canlet.2014.08.024_bib0150","doi-asserted-by":"crossref","first-page":"15440","DOI":"10.1074\/jbc.M110.181180","article-title":"Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer","volume":"286","author":"Turner","year":"2011","journal-title":"J. Biol. Chem"},{"issue":"6","key":"10.1016\/j.canlet.2014.08.024_bib0155","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jmcb\/mjt038","article-title":"Thromboxane A2 receptor alpha promotes tumor growth through an autoregulatory feedback pathway","volume":"5","author":"Huang","year":"2013","journal-title":"J. Mol. Cell Biol"},{"issue":"9","key":"10.1016\/j.canlet.2014.08.024_bib0160","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/carcin\/bgp161","article-title":"Activation of thromboxane A(2) receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells","volume":"30","author":"Li","year":"2009","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.canlet.2014.08.024_bib0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.lungcan.2009.09.009","article-title":"Thromboxane receptor alpha mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells","volume":"69","author":"Wei","year":"2010","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2014.08.024_bib0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.canlet.2014.08.024_bib0175","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1006\/bbrc.2000.2859","article-title":"Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages","volume":"272","author":"Hinz","year":"2000","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"5","key":"10.1016\/j.canlet.2014.08.024_bib0180","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1460-9568.1997.tb01444.x","article-title":"Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs","volume":"9","author":"Minghetti","year":"1997","journal-title":"Eur. J. Neurosci"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0185","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.bbrc.2005.10.051","article-title":"Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42\/44 mitogen-activated protein kinases","volume":"338","author":"Rosch","year":"2005","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"20","key":"10.1016\/j.canlet.2014.08.024_bib0190","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.yexcr.2010.07.003","article-title":"Thromboxane synthase suppression induces lung cancer cell apoptosis via inhibiting NF-kappaB","volume":"316","author":"Leung","year":"2010","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.canlet.2014.08.024_bib0195","first-page":"1705","article-title":"PGE2, PGF2 alpha, and TXB2 biosynthesis by human rheumatoid synovia","volume":"8","author":"Blotman","year":"1980","journal-title":"Adv. Prostaglandin Thromboxane Res"},{"issue":"1","key":"10.1016\/j.canlet.2014.08.024_bib0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1054\/plef.2002.0381","article-title":"Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography\/tandem mass spectrometry","volume":"67","author":"Takabatake","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"6\u20137","key":"10.1016\/j.canlet.2014.08.024_bib0205","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/BF01978760","article-title":"The influence of synovial fluid from patients with rheumatoid arthritis on the proliferation of peripheral blood lymphocytes and the prostanoid release from monocytes","volume":"11","author":"Seitz","year":"1981","journal-title":"Agents Actions"},{"issue":"7","key":"10.1016\/j.canlet.2014.08.024_bib0210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/ard.44.7.438","article-title":"Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus","volume":"44","author":"Seitz","year":"1985","journal-title":"Ann. Rheum. Dis"},{"issue":"5","key":"10.1016\/j.canlet.2014.08.024_bib0215","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.freeradbiomed.2010.06.009","article-title":"Determinants of thromboxane biosynthesis in rheumatoid arthritis: role of RAGE and oxidant stress","volume":"49","author":"Ferrante","year":"2010","journal-title":"Free Radic. Biol. Med"},{"issue":"3","key":"10.1016\/j.canlet.2014.08.024_bib0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/03009747709095440","article-title":"Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis","volume":"6","author":"Trang","year":"1977","journal-title":"Scand. J. Rheumatol"},{"issue":"6","key":"10.1016\/j.canlet.2014.08.024_bib0225","first-page":"1110","article-title":"[Thromboxane A2 receptor induces proliferation of rheumatoid arthritis synovial cells by up-regulation of cyclooxygenase-2]","volume":"30","author":"Chu","year":"2014","journal-title":"Zhongguo Bing Li Sheng Li Za Zhi"},{"issue":"4","key":"10.1016\/j.canlet.2014.08.024_bib0230","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1213\/01.ANE.0000048370.91644.77","article-title":"COX-2 inhibition for postoperative analgesia","volume":"96","author":"Schwarz","year":"2003","journal-title":"Anesth. Analg"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00002018-200831020-00004","article-title":"Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands","volume":"31","author":"Layton","year":"2008","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.canlet.2014.08.024_bib0240","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00535-013-0784-3","article-title":"Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors","volume":"48","author":"Lai","year":"2013","journal-title":"J. Gastroenterol"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1476-5381.2010.01035.x","article-title":"Inhibition of cyclooxygenase-2 prevents adverse effects induced by phosphodiesterase type 4 inhibitors in rats","volume":"162","author":"Peter","year":"2011","journal-title":"Br. J. Pharmacol"},{"issue":"13","key":"10.1016\/j.canlet.2014.08.024_bib0250","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/00002018-200326130-00001","article-title":"Balancing gastroprotection and cardioprotection with selective cyclo-oxygenase-2 inhibitors: clinical implications","volume":"26","author":"Meagher","year":"2003","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/187152906777441803","article-title":"Cyclooxygenase-2 inhibitors: a painful lesson","volume":"6","author":"Sanghi","year":"2006","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"issue":"15","key":"10.1016\/j.canlet.2014.08.024_bib0260","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehr421","article-title":"Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib","volume":"33","author":"Back","year":"2012","journal-title":"Eur. Heart J."},{"issue":"Suppl. 1","key":"10.1016\/j.canlet.2014.08.024_bib0265","first-page":"44","article-title":"[Management of difficult situations in patients with RA: cancer]","volume":"5","author":"Andreu","year":"2009","journal-title":"Reumatol. Clin"},{"issue":"5","key":"10.1016\/j.canlet.2014.08.024_bib0270","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/rheumatology\/39.5.533","article-title":"Methotrexate as a preferential cyclooxygenase 2 inhibitor in whole blood of patients with rheumatoid arthritis","volume":"39","author":"Mello","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.canlet.2014.08.024_bib0275","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.mehy.2012.05.019","article-title":"Itraconazole: its possible role in inhibiting angiogenesis in rheumatoid arthritis","volume":"79","author":"Sheikh","year":"2012","journal-title":"Med. Hypotheses"},{"issue":"3","key":"10.1016\/j.canlet.2014.08.024_bib0280","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3892\/or.2013.2561","article-title":"Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells","volume":"30","author":"Yan","year":"2013","journal-title":"Oncol. Rep"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0285","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.lungcan.2012.03.005","article-title":"Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer","volume":"77","author":"Lim","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2014.08.024_bib0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biopha.2013.11.006","article-title":"Aspirin reduces lung cancer metastasis to regional lymph nodes","volume":"68","author":"Ogawa","year":"2014","journal-title":"Biomed. Pharmacother"},{"issue":"10","key":"10.1016\/j.canlet.2014.08.024_bib0295","first-page":"1416","article-title":"[Regulatory roles of compound danshen in the downstream path of cyclooxygenases in rheumatold arthritis patients' synovium]","volume":"33","author":"Huang","year":"2013","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"4","key":"10.1016\/j.canlet.2014.08.024_bib0300","doi-asserted-by":"crossref","first-page":"e93690","DOI":"10.1371\/journal.pone.0093690","article-title":"18beta-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.canlet.2014.08.024_bib0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000356677","article-title":"Glycyrrhizin suppresses lung adenocarcinoma cell growth through inhibition of thromboxane synthase","volume":"33","author":"Huang","year":"2014","journal-title":"Cell. Physiol. Biochem"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514004649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383514004649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T05:10:11Z","timestamp":1589260211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383514004649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0304383514004649"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2014.08.024","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cyclooxygenase-2\/thromboxane A2 pathway: a bridge from rheumatoid arthritis to lung cancer?","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2014.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}